Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
438.48
361.20
301.98
223.82
337.70
243.02
235.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
438.48
361.20
301.98
223.82
337.70
243.02
235.03
Raw Material Cost
253.22
266.01
195.32
148.86
247.06
144.14
164.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-2.42
-62.35
-23.00
3.09
-66.11
10.96
-17.33
Employee Cost
37.44
34.81
27.20
25.69
24.02
18.03
19.27
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
45.46
40.19
32.06
26.07
30.19
18.23
17.77
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
17.05
17.56
16.40
7.36
11.31
6.13
5.59
Total Expenditure (Excl Depreciation)
350.75
296.22
247.98
211.07
246.47
197.49
189.40
Operating Profit (PBDIT) excl Other Income
87.73
64.98
54.00
12.75
91.23
45.53
45.63
Other Income
2.03
2.67
1.32
1.41
2.64
1.31
1.23
Operating Profit (PBDIT)
89.76
67.65
55.32
14.16
93.87
46.84
46.86
Interest
11.58
9.27
11.89
10.09
9.78
5.67
6.41
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
78.18
58.38
43.43
4.07
84.09
41.17
40.45
Depreciation
19.77
17.00
15.59
16.03
16.08
11.11
10.69
Profit Before Tax
58.41
41.37
27.84
-11.95
68.01
30.06
29.76
Tax
14.57
11.14
6.99
-2.49
19.80
9.63
10.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
43.84
30.24
20.86
-9.46
48.21
20.43
19.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
43.84
30.24
20.86
-9.46
48.21
20.43
19.03
Share in Profit of Associates
1.96
0.34
0.21
-5.32
-1.62
-2.43
-1.38
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
45.80
30.58
21.07
-14.78
46.59
18.00
17.65
Equity Capital
9.37
8.47
8.47
8.47
8.47
8.47
8.47
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.89
3.61
2.49
-1.74
5.5
2.13
2.08
Diluted Earnings per share
5.13
3.61
2.49
-1.75
5.5
2.13
2.09
Operating Profit Margin (Excl OI)
20.01%
17.99%
17.88%
5.7%
27.02%
18.74%
19.41%
Gross Profit Margin
17.83%
16.16%
14.38%
1.82%
24.9%
16.94%
17.21%
PAT Margin
10.0%
8.37%
6.91%
-4.23%
14.28%
8.41%
8.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 21.40% vs 19.61% in Sep 2024
Consolidate Net Profit
Growth in half year ended Sep 2025 is 49.77% vs 45.14% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 35.01% vs 20.33% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 24.92% vs -22.04% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Sep 2024
Compare Half Yearly Results Of SMS Pharma. With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
438.48
698.90
-260.42
-37.26%
Other Operating Income
0.00
0.00
0.00
Total Operating income
438.48
698.90
-260.42
-37.26%
Raw Material Cost
253.22
400.70
-147.48
-36.81%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-2.42
-87.60
85.18
97.24%
Employee Cost
37.44
132.50
-95.06
-71.74%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
45.46
0.00
45.46
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
17.05
221.00
-203.95
-92.29%
Total Expenditure (Excl Depreciation)
350.75
666.60
-315.85
-47.38%
Operating Profit (PBDIT) excl Other Income
87.73
32.30
55.43
171.61%
Other Income
2.03
2.90
-0.87
-30.00%
Operating Profit (PBDIT)
89.76
35.20
54.56
155.00%
Interest
11.58
32.00
-20.42
-63.81%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
78.18
3.20
74.98
2,343.12%
Depreciation
19.77
80.60
-60.83
-75.47%
Profit Before Tax
58.41
-77.40
135.81
175.47%
Tax
14.57
-20.10
34.67
172.49%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
43.84
-57.30
101.14
176.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
43.84
-57.30
101.14
176.51%
Share in Profit of Associates
1.96
0.00
1.96
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
45.80
-57.30
103.10
179.93%
Equity Capital
9.37
24.70
-15.33
-62.06%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.89
-4.64
9.53
205.39%
Diluted Earnings per share
5.13
-4.65
9.78
210.32%
Operating Profit Margin (Excl OI)
20.01%
4.70%
0.00
15.31%
Gross Profit Margin
17.83%
0.47%
0.00
17.36%
PAT Margin
10.00%
-8.33%
0.00
18.33%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 438.48 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 21.40% vs 19.61% in Sep 2024
Half Yearly - Consolidate Net Profit
Consolidate Net Profit 45.80 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 49.77% vs 45.14% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 87.73 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 35.01% vs 20.33% in Sep 2024
Half Yearly - Interest
Interest 11.58 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 24.92% vs -22.04% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.01%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Sep 2024






